Built for Safety,
Engineered for Efficiency
Built for Safety,
Engineered for
Efficiency
Built for Safety,
Engineered for Efficiency
Built for Safety,
Engineered for Efficiency
Injectable drug compounding, now in the hands of robots.
Injectable drug compounding, now in the hands of robots.
Injectable drug compounding, now in the hands of robots.
Injectable drug compounding, now in the hands of robots.
Discover how PharmaRobotics is transforming the hospital ward →
Discover how PharmaRobotics is
transforming the hospital ward →
Discover how PharmaRobotics is
transforming the hospital ward →
Compounding Accuracy
(margin of error)
Compounding
Throughput
Max Concurrent
Compounding Tasks
Compatible Injectable Drugs
(powder & liquid)
Compounding Accuracy
(margin of error)
Compounding
Throughput
Max Concurrent
Compounding Tasks
Compatible Injectable Drugs
(powder & liquid)
Compounding Accuracy
(margin of error)
Compounding
Throughput
Max Concurrent
Compounding Tasks
Compatible Injectable Drugs
(powder & liquid)
The Problem
The Problem
Manual, repetitive drug compounding
has reached its limit
Manual, repetitive drug compounding
has reached its limit
Manual, repetitive drug compounding
has reached its limit
Medication errors have increased 2.7-fold in four years, while the nursing workforce remains half the OECD average.
The structural risks in the compounding process cannot be solved by human effort alone.
Medication errors have increased 2.7-fold in four years, while the nursing workforce remains half the OECD average. The structural risks in the compounding process cannot be solved by human effort alone.
10,089
10,089
Medication Error Incidents (2023)
Medication Error Incidents (2023)
Medication Error Incidents (2023)
2.7-fold in four years
2.7-fold in four years
2.7x
2.7x
Increase in 4 Years
Increase in 4 Years
Increase in 4 Years
2019 → 2023
2019 → 2023
4.4
4.4
Nurses per 1,000 Population
Nurses per 1,000 Population
Nurses per 1,000 Population
Half the OECD Average of 8
Half the OECD Average of 8
300
300
Daily Repetitive Compounding Tasks per Ward
Daily Repetitive Compounding Tasks per Ward
Daily Repetitive Compounding Tasks per Ward
about 1 hour per shift
about 1 hour per shift
Our Solution
Our Solution
Let robots handle compounding
free clinical staff for what matters most
Let robots handle compounding
free clinical staff for what matters most
Let robots handle compounding
free clinical staff for what matters most
From e-prescription integration to compounding, dispensing,
and inventory management The PHAR-ROS platform eliminates
compounding errors at the source, giving nurses back their
time to spend with patients.
From e-prescription integration to compounding, dispensing,
and inventory management The PHAR-ROS platform eliminates
compounding errors at the source, giving nurses back their
time to spend with patients.
From e-prescription integration to compounding, dispensing,
and inventory management The PHAR-ROS platform eliminates
compounding errors at the source, giving nurses back their
time to spend with patients.
01
Safety
Safety
Eliminating compounding errors at the source through e-prescription integration
01
Safety
Safety
Eliminating compounding errors at the source through e-prescription integration
01
Safety
Safety
Eliminating compounding errors at the source through e-prescription integration
02
Efficiency
Efficiency
High-speed compounding that delivers the effect of additional staffing
02
Efficiency
Efficiency
High-speed compounding that delivers the effect of additional staffing
02
Efficiency
Efficiency
High-speed compounding that delivers the effect of additional staffing
03
Consistency
Consistency
Compounding in a clean environment secured by HEPA (H13) filtration
03
Consistency
Consistency
Compounding in a clean environment secured by HEPA (H13) filtration
03
Consistency
Consistency
Compounding in a clean environment secured by HEPA (H13) filtration
Our Solution
Let robots handle compounding
free clinical staff for what matters most
From e-prescription integration to compounding, dispensing,
and inventory management The PHAR-ROS platform eliminates
compounding errors at the source, giving nurses back their
time to spend with patients.
01
Safety
Safety
Eliminating compounding errors at the source through e-prescription integration
02
Efficiency
Efficiency
High-speed compounding that delivers the effect of additional staffing
03
Consistency
Consistency
Compounding in a clean environment secured by HEPA (H13) filtration
“ PHAR-ROS ONE is a proven solution.”
“ PHAR-ROS ONE is a proven solution.”
PHAR-ROS ONE
is a proven solution.
PHAR-ROS ONE
PHAR-ROS ONE
General-Purpose Automated Injectable Drug Compounding Robot PHAR-ROS ONE
General-Purpose Automated Injectable Drug Compounding Robot PHAR-ROS ONE
General-Purpose Automated Injectable Drug Compounding Robot PHAR-ROS ONE
PHAR-ROS ONE is a first-generation platform that fully automates injectable drug compounding at the hospital ward.
It performs automated drug selection, dispensing, and
packaging in a single unit.
PHAR-ROS ONE is a first-generation platform that fully automates injectable drug compounding at the hospital ward. It performs automated drug selection, dispensing, and packaging in a single unit.
PHAR-ROS ONE is a first-generation platform that fully automates injectable drug compounding at the hospital ward.
It performs automated drug selection, dispensing, and
packaging in a single unit.
Product Definition Motorized/Electric-Powered Drug
Compounding Device · Class II Medical Device
· Product Definition
Motorized/Electric-Powered Drug Compounding Device · Class II Medical Device
Product Definition Motorized/Electric-Powered Drug
Compounding Device · Class II Medical Device
Key Features One-stop automated drug selection,
dispensing, and packaging using dedicated consumables
· Key Features
One-stop automated drug selection,
dispensing, and packaging using dedicated consumables
Key Features One-stop automated drug selection,
dispensing, and packaging using dedicated consumables
Compatible Drugs 500 Injectable Drug Types (powder & liquid)
— antibiotics, vaccines, dermatologic agents, and more
· Compatible Drugs
500 Injectable Drug Types (powder & liquid) antibiotics, vaccines, dermatologic agents, and more
Compatible Drugs 500 Injectable Drug Types (powder & liquid) — antibiotics, vaccines, dermatologic agents, and more
Installation Nursing Ward Injection Preparation Room
(one unit per ward)
· Installation
Nursing Ward Injection Preparation Room (one unit per ward)
Installation Nursing Ward Injection Preparation Room
(one unit per ward)
Key Advantages
Key Advantages
Three Reasons PHAR-ROS ONE Is Different
Three Reasons
PHAR-ROS ONE Is Different
Three Reasons
PHAR-ROS ONE Is Different
Three Reasons
PHAR-ROS ONE Is Different
Consistent aseptic compounding, a scalable modular structure,
and workflow integration built for nursing practice.
Consistent aseptic compounding, a scalable modular structure,
and workflow integration built for nursing practice.
Consistent aseptic compounding, a scalable modular structure,
and workflow integration built for nursing practice.
Consistent Aseptic Compounding
Built on dedicated prefilled syringes, the system maintains consistent aseptic quality using 99.9% medical-grade UV disinfection and a HEPA (H13) clean environment.
Consistent Aseptic Compounding
Built on dedicated prefilled syringes, the system maintains consistent aseptic quality using 99.9% medical-grade UV disinfection and a HEPA (H13) clean environment.
Consistent Aseptic Compounding
Built on dedicated prefilled syringes, the system maintains consistent aseptic quality using 99.9% medical-grade UV disinfection and a HEPA (H13) clean environment.
Modular, Interchangeable Architecture
Modules can be swapped to switch between general-purpose and high-complexity compounding, with a structure designed to expand across future generations.
Modular, Interchangeable Architecture
Modules can be swapped to switch between general-purpose and high-complexity compounding, with a structure designed to expand across future generations.
Modular, Interchangeable Architecture
Modules can be swapped to switch between general-purpose and high-complexity compounding, with a structure designed to expand across future generations.
Integrated Nursing Workflow
OCS (HL7) integration allows the system to fit seamlessly into ward dispensing and medication administration workflows.
Integrated Nursing Workflow
OCS (HL7) integration allows the system to fit seamlessly into ward dispensing and medication administration workflows.
Integrated Nursing Workflow
OCS (HL7) integration allows the system to fit seamlessly into ward dispensing and medication administration workflows.
PHAR-ROS ONE
PHAR-ROS ONE
Seamless Automation,
from Prescription to Administration
Seamless Automation,
from Prescription to Administration
Seamless Automation,
from Prescription to Administration
A 6-step aseptic compounding process that runs without human intervention,
from the moment an e-prescription is received to administration at the ward.
A 6-step aseptic compounding process that runs without human intervention,
from the moment an e-prescription is received to administration at the ward.
Step 1. E-Prescription Transmission
The e-prescription is sent from the central server system to PHAR-ROS ONE.
Step 1.
E-Prescription Transmission
The e-prescription is sent from the central server system to PHAR-ROS ONE.
Step 2. Automatic Prescription Verification
PHAR-ROS ONE automatically verifies the received e-prescription.
Step 2.
Automatic Prescription Verification
PHAR-ROS ONE automatically verifies the received e-prescription.
Step 3. Cross-Verification
The loaded medication is cross-checked against the e-prescription to ensure data integrity.
Step 3.
Cross-Verification
The loaded medication is cross-checked against the e-prescription to ensure data integrity.
Step 4. Compounding Start
Automated compounding begins once the operator presses Start.
Step 4.
Compounding Start
Automated compounding begins once the operator presses Start.
Step 5. Automated Compounding
PHAR-ROS ONE automatically compounds the injectable drug in an aseptic environment.
Step 5.
Automated Compounding
PHAR-ROS ONE automatically compounds the injectable drug in an aseptic environment.
Step 6. Retrieval & Administration
The completed injectable is retrieved and administered to the patient at the ward.
Step 6.
Retrieval & Administration
The completed injectable is retrieved and administered to the patient at the ward.
Top-Tier Compounding Performance, Proven in Numbers
Top-Tier Compounding Performance, Proven in Numbers
±5% compounding accuracy, an average of 60 doses per hour, up to 20 concurrent compounding tasks — rated performance verified through certified testing
±5%
±5%
Compounding Accuracy (margin of error)
Compounding Accuracy
(margin of error)
60 dose/h
60 dose/h
Average Compounding Speed
Average Compounding Speed
20
20
Max Concurrent Compounding Tasks
Max Concurrent Compounding Tasks
Max Vials
20 (2–20 mL)
Filtered Saline Syringes
20
Clean Environment
HEPA H13 · ISO Class 5
Dimensions
1,000 × 800 × 1,800 mm
Prescription Integration
OCS (HL7)
Medical Device Class
Class II Medical Device
Top-Tier Compounding Performance, Proven in Numbers
±5% compounding accuracy, an average of 60 doses per hour, up to 20 concurrent compounding tasks — rated performance verified through certified testing
±5%
Compounding Accuracy
(margin of error)
60 dose/h
Average Compounding Speed
20
Max Concurrent
Compounding Tasks
Max Vials
20 (2–20 mL)
Filtered Saline Syringes
20
Clean Environment
HEPA H13 · ISO Class 5
Dimensions
1,000 × 800 × 1,800 mm
Prescription Integration
OCS (HL7)
Medical Device Class
Class II Medical Device
Technology
Technology
Patents and Infrastructure
That Create a High Barrier to Entry
Patents and Infrastructure
That Create a High Barrier to Entry
Patents and Infrastructure
That Create a High Barrier to Entry
From core process patents to PCT international applications, backed by a dual GMP
manufacturing system covering both the robot and its consumables.
From core process patents to PCT international applications, backed by a dual GMP manufacturing system covering both the robot and its consumables.
지식재산권 출원
지식재산권 출원
지식재산권 출원
인증내용
인증내용
인증내용
PCT 국제출원
PCT 국제출원
PCT 국제출원
인증내용
인증내용
식염수 프리필드 시린지 KGMP 생산시설
식염수 프리필드 시린지 KGMP 생산시설
준비중
준비중
2등급 GMP 제조시설
2등급 GMP 제조시설
준비중
준비중
FDA 인허가 프로세스
FDA 인허가 프로세스
준비중
준비중
OUR MISSION
OUR MISSION
Safety Guardian — Protecting Patient Safety
Safety Guardian — Protecting Patient Safety
Safety Guardian — Protecting Patient Safety
Safety Guardian
— Protecting Patient Safety
PharmaRobotics innovates the medication process
to advance patient safety and clinical efficiency together.
PharmaRobotics innovates the medication process
to advance patient safety and clinical efficiency together.
Company Name
Company Name
Pharma Robotics Co., Ltd.
Pharma Robotics Co., Ltd.
Founded
Founded
June 2024
June 2024
Headquarters & Pharmaceutical GMP
Headquarters & Pharmaceutical GMP
Jeonju Innovation Startup Hub
Jeonju Innovation Startup Hub
R&D Center & Medical Device GMP
R&D Center & Medical Device GMP
Geumcheon-gu, Seoul
Geumcheon-gu, Seoul
Certifications
Certifications
Venture Business · Corporate R&D Center
Venture Business · Corporate R&D Center
Management
Management
CEO Jecheong Yoo, Ph.D. in Engineering
CEO Jecheong Yoo, Ph.D. in Engineering
CEO Jecheong Yoo — Ph.D. in Engineering, former Director of the Rehabilitation Engineering
Research Institute, and former President of the Korean Society of Rehabilitation Robotics.
Backed by a leadership team with expertise in pharmacy, robotics, regulatory affairs, and sales.
CEO Jecheong Yoo — Ph.D. in Engineering, former Director of the Rehabilitation Engineering Research Institute, former President of the Korean Society of Rehabilitation Robotics. Backed by a leadership team with expertise in pharmacy, robotics, regulatory affairs, and sales.
CEO Jecheong Yoo —
Ph.D. in Engineering, former Director of the Rehabilitation Engineering Research Institute, former President of the Korean Society of Rehabilitation Robotics. Backed by a leadership team with expertise in pharmacy, robotics, regulatory affairs, and sales.
Clinical Partner Hospitals & Collaborators
Clinical Partner Hospitals & Collaborators
Clinical Partner Hospitals & Collaborators
Milestones
Milestones
Two Years In —
Moving Faster Than the Numbers Show
Two Years In —
Moving Faster Than the Numbers Show
Two Years In —
Moving Faster Than the Numbers Show
Two Years In —
Moving Faster Than the Numbers Show
Since its founding in June 2024, Pharma Robotics has moved at remarkable speed
Since its founding in June 2024, Pharma Robotics has moved at remarkable speed
2024
Jun
Pharma Robotics Co., Ltd. founded
Aug
Signed joint commercialization MOU with Singapore medical corporation HAQQUL PTE. LTD.
Oct
Relocated headquarters to Seoul Startup Center (Dongjak)
Nov
Signed MOU with OO University Medical Center for usability evaluation and PoC
Dec
Completed KRW 300 million Seed round investment from Scale-Up Partners LLC
2025
Jan
Signed MOU with Jeollabuk-do Province and Jeonju City for KRW 17.5 billion investment in National Carbon Industrial Complex
Feb
Completed Venture Business & Corporate-affiliated R&D Center certifications
Mar
Signed PoC MOU with OO University Hospital
Apr
Selected for 2025 Chogyeokcha (Super-Gap) 1000+ Program (KRW 600 million, 3 years)
May
Selected for Jeollabuk-do Bio-Industry Development R&D Support Program (KRW 900 million, 3 years)
Jun
Selected for 2025 TIPS Re-Challenge Track (KRW 500 million, 2 years)
Jun
Selected for 2025 National Advanced Strategic Industry Technology Innovation Loan Program (KRW 5 billion)
Jul
Relocated headquarters to Jeollabuk-do and began construction of KGMP injectable drug manufacturing facility
2026
Jul
Selected for 2nd Bio-Health Industrial Technology R&D Program (KRW 3.113 billion, 4 years)
2024
Jun
Pharma Robotics Co., Ltd. founded
Aug
Signed joint commercialization MOU with Singapore medical corporation HAQQUL PTE. LTD.
Oct
Relocated headquarters to Seoul Startup Center (Dongjak)
Nov
Signed MOU with OO University Medical Center for usability evaluation and PoC
Dec
Completed KRW 300 million Seed round investment from Scale-Up Partners LLC
2025
Jan
Signed MOU with Jeollabuk-do Province and Jeonju City for KRW 17.5 billion investment in National Carbon Industrial Complex
Feb
Completed Venture Business & Corporate-affiliated R&D Center certifications
Mar
Signed PoC MOU with OO University Hospital
Apr
Selected for 2025 Chogyeokcha (Super-Gap) 1000+ Program (KRW 600 million, 3 years)
May
Selected for Jeollabuk-do Bio-Industry Development R&D Support Program (KRW 900 million, 3 years)
Jun
Selected for 2025 TIPS Re-Challenge Track (KRW 500 million, 2 years)
Jun
Selected for 2025 National Advanced Strategic Industry Technology Innovation Loan Program (KRW 5 billion)
Jul
Relocated headquarters to Jeollabuk-do and began construction of KGMP injectable drug manufacturing facility
2026
Jul
Selected for 2nd Bio-Health Industrial Technology R&D Program (KRW 3.113 billion, 4 years)
Contact
Contact
Let’s Start a Conversation
About Adoption & Partnership
Let’s Start a Conversation
About Adoption & Partnership
Let’s Start a Conversation
About Adoption & Partnership
Whether it’s hospital adoption, investment, or global partnership, we respond within 2 business days.
Whether it’s hospital adoption, investment,
or global partnership, we respond within 2 business days.
Whether it’s hospital adoption, investment, or global partnership,
we respond within 2 business days.
Consultations Currently Open
We respond within 2 business days.
ecryu007@pharmarobotics.co.kr
Address
Headquarters — Jeonju Innovation Startup Hub · R&D Center — Geumcheon-gu, Seoul